NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $72 | -18.2% | 125 | 0.0% | 0.00% | – |
Q1 2023 | $88 | -68.8% | 125 | 0.0% | 0.00% | – |
Q4 2022 | $282 | – | 125 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 125 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 125 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 125 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | -33.3% | 125 | 0.0% | 0.00% | – |
Q2 2020 | $3,000 | +50.0% | 125 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | -33.3% | 125 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | +50.0% | 125 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 125 | +66.7% | 0.00% | – |
Q1 2019 | $3,000 | +50.0% | 75 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -33.3% | 75 | +50.0% | 0.00% | – |
Q3 2018 | $3,000 | – | 50 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |